Company overview

PT Kalbe Farma

Name

PT Kalbe Farma

Entity type

PT (Limited Liability Company)

Province

DKI Jakarta

Regency

Kota Adm. Jakarta Pusat

District

Cempaka Putih

Village

Cempaka Putih Timur

Address

Jl. Letjen Soeprapto Kav. 4 No 1

Postal code

10510

Country

Indonesia

Primary goods traded

  • 💊65.8% — Medicaments (300490)
  • 💉16.4% — Blood, human or animal, antisera, other blood fractions and immunological products (300212)
  • 💉8.4% — Blood, human or animal, antisera, other blood fractions and immunological products (300215)
  • 5.9% — Food preparations (210690)
  • 3.4% — Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 (293499)
BPOM Products
Register NumberBrandForm
25 March 2021
Babassu Oil
NA18181204635BLEPHASEPGel
25 March 2021
Babassu Oil
NA18181204635BLEPHASEPGel
8 February 2024
Babassu Oil
NA18181204635BLEPHASEPGel
10 June 2025
TROLIT
SD171250301-Serbuk Oral
21 September 2018
CEREBROVIT GINKGO
SD071332421-Kapsul
30 May 2018
NEURALGIN PAIN
QD131711581-Krim
30 May 2018
NEURALGIN PAIN
QD131711581-Krim
19 September 2019
H2 HEALTH & HAPPINESS Superba Krill Oil
SI144305191-Kapsul Lunak
18 December 2019
H2 HEALTH & HAPPINESS SHARK LIVER OIL
SI154305571-Kapsul Lunak
9 October 2018
RG-CHOLINE
SD091536031-Kaplet Salut Selaput
0 of 50 row(s) selected.
Main Trading Partners
PartnerTypeTotal ValuePercentage
Baxter Healthcare (Asia) Pte Ltdseller$39,094,14220.91%
Kalbe International Pte. Ltd.buyer$22,978,69512.29%
Innogene Kalbiotech Pte. Ltd.seller$18,922,60210.12%
Gan & Lee Pharmaceuticalsseller$2,421,1651.30%
Vantive Pte. Ltd.seller$2,209,2261.18%
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
Data SourceHS CodeDescriptionBuyerBuyer CountrySellerSeller Country
29 January 2025BEMedicaments, N.O.S., DosageKalbe FarmaIDDsv Air & Sea-
19 December 2019ID30021500Rituxikal 500 Mg, Bn.11927,11929,11969, Jml: 3840 Vl Mk190283Kalbe InternationalIDInnogene Kalbiotech Pte LimitedSG$1,209,600.00
30 June 2020ID30049099Cernevit - Multivitamin-Serbuk Injeksi, Bacth No.Le20c035, Le20c032, Le20c034, Jml : 177370 Vl Mk200119Kalbe InternationalIDBaxter Healthcare Asia Pte LimitedSG$1,083,762.83
23 June 2020ID30049099Cernevit - Multivitamin-Serbuk Injeksi, Bacth No. Le20c033, Le20c027, Jml : 170980 Vl Mk200119Kalbe InternationalIDBaxter Healthcare Asia Pte LimitedSG$1,044,790.76
8 July 2025ID30021500Herzemab(trastuzumab 440 Mg)-Trastuzumab Combipack(with Bwfi),bn: Bf25000538Kalbe FarmaIDInnogene Kalbiotech Pte Limited$1,036,415.00
4 October 2022ID30021210Octalbin 25% 100 Ml (Pharmaceuticals), Batch.No. K223a6872, Jml: 12600 Bx Mk220071Kalbe InternationalIDOctapharma AgCH$976,500.00
9 November 2020ID30049099Cernevit-Multivitamin-Serbuk Injeksi,bacth No.Le20c035,le20c034,le20c032,le20c040, Jml:150910vl 418,024,072,120Kalbe InternationalIDBaxter Healthcare Asia Pte LimitedSG$911,059.00
19 September 2018ID84798920Coater Model Xl Cota 750, Jml: 1 Unit Umk170012-CKalbe InternationalIDHuettlin GmbhDE$871,149.84
18 May 2022ID30021210Octalbin 25% 100 Ml (Pharmaceuticals), Batch.No. P212a6872,jml:12600 Bx Mk220006,220007Kalbe InternationalIDOctapharma AgCH$866,250.00
21 April 2022ID30021210Octalbin 25% 100 Ml (Pharmaceuticals), Batch.No. K203a6872, Jml: 12600 Bx Mk210319Kalbe InternationalIDOctapharma AgCH$866,250.00
0 of 20 row(s) selected.